(1)
Centessa Pharmaceuticals ( Centessa ), a pharmaceutical company consisting of 10 subsidiary companies advancing a portfolio of high conviction programs with strong biological validation, today announced key additions to its leadership team. Gregory Weinhoff, M.D., MBA, joined the team as chief financial officer, while Mary Lynne Hedley, Ph.D., Robert M. Califf, M.D., MACC, and Samarth Kulkarni, Ph.D., joined Centessa s board of directors effective February 23, 2021. Centessa launched last month with a goal of redefining pharmaceutical R&D productivity through an asset-centric model that we believe has the potential to support the advancement of novel programs by industry-leading experts in their respective fields, said Saurabh Saha, M.D., Ph.D., chief executive officer of Centessa. Each member of our team brings industry-leading qualifications and differentiated perspectives to help guide the expansion of our organization. We are thrilled to welcome Greg, Mary Lynne, Robert
The New Frontiers in Biomedical Research will continue its COVID-19 series with the first lecture in the Spring Quarter. The seminar will focus on Health Communication during COVID-19 Pandemic at 3:30 p.m. CST Monday, March 29, on WebEx.
Dr. Heidi Y. Lawrence, Associate Professor of English at George Mason University and Scott Barrows, Director of OSF Innovation Design Lab, Jump Trading Simulation and Education Center; Clinical Assistant Professor of Emergency Medicine at University of Illinois College of Medicine Peoria; and Clinical Assistant Professor in Biomedical Visualization at the University of Illinois Chicago Medical Center, will share their recent involvement in written and visual communication related to COVID-19 vaccine education.
A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.
The 6th Annual Clinical Research as a Care Option (CRAACO) Conference Announced their 2021 Keynotes and Notable Speakers Presented by the Conference Forum
Share Article
The Conference Forum announced the 6th annual CRAACO: Clinical Research as a Care Option conference will take place in a live virtual format on April 26-27, 2021. By facilitating conversations throughout the pharma and healthcare ecosystems, we hope to sustain rapid progress in making clinical research accessible, equitable and affordable to patients and bring therapies to market faster and more efficiently. NEW YORK (PRWEB) March 05, 2021 The Conference Forum announced the 6th annual CRAACO: Clinical Research as a Care Option conference will take place in a live virtual format on April 26-27, 2021.